Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Eliem Therapeutics

Eliem Therapeutics

Eliem Therapeutics is a treatments for neuronal Excitability Disorders.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
Board of Directors
‌
Simon Tate
0
‌
Judith Dunn
0
‌
Adam Rosenberg
0
‌
Liam Ratcliffe
0
‌
Andrew Levin
0
Leone Patterson
Leone Patterson
0
‌
Bob Azelby
0
CEO
‌
Bob Azelby
0
CFO
‌
Erin Lavelle
0
CIK Number
1,768,446
0
Legal Name
Eliem Therapeutics, Inc.
Company Operating Status
Active
COO
‌
Erin Lavelle
0
Country
United Kingdom
United Kingdom
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
careersUK@eliemtx.com
Full Address
23515 NE Novelty Hill Road, Suite B221 #125 Redmond, WA 98053, USA
Industry
Biomedical engineering
Biomedical engineering
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Healthcare
Healthcare
Medicine
Medicine
‌
Neurobiology
Technology
Technology
Invested in
LifeArc
LifeArc
Intermediate Capital Group
Intermediate Capital Group
Access Industries
Access Industries
RA Capital Management
RA Capital Management
Investors
LifeArc
LifeArc
Intermediate Capital Group
Intermediate Capital Group
0
Access Biotechnology
Access Biotechnology
IRS Number
832,273,741
0
Latest Funding Round Date
May 24, 2021
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/eliemtx
Location
Redmond, Washington
Redmond, Washington
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles...399262-42
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
ELYM
0
Ticker Symbol
ELYM
Total Funding Amount (USD)
140,000,000
Official Website
eliemtx.com

Find more companies like Eliem Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo